IGEA Pharma N.V.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,573,700.
Profit Margin
| 2017 | 6.49K | -278.05K | -4278.47% |
|---|---|---|---|
| 2018 | 5.14K | -1.24M | -24179.7% |
| 2019 | 1.24K | -1.70M | -136752.68% |
| 2020 | 64.39K | -927.02K | -1439.66% |
| 2021 | 103.3K | -1.36M | -1317.81% |
| 2022 | 0 | -11.68M |
IGPH.SW Income Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 103.3K | 64.39K | 1.24K | 5.14K | 6.49K |
Cost of revenue | 0 | 126.2K | 236.51K | 392.70K | 173.01K | 170.14K |
Gross profit | 0 | -22.9K | -172.12K | -391.45K | -167.86K | -163.64K |
Operating exp. | ||||||
Research and development | 13.4K | 148.9K | 48.21K | 109.00K | 0 | 0 |
Selling and marketing | 0 | 200 | 143.33K | 471.98K | 0 | 0 |
Total operating expenses | 9.57M | 1.12M | 612.54K | 1.33M | 1.11M | 154.46K |
Operating income | -10.45M | -1.14M | -784.66K | -1.72M | -1.28M | -318.11K |
Other income (expenses), net | -1.29M | -113.9K | -140.81K | 19.55K | 44.39K | -41.23K |
Income before tax | -11.75M | -1.25M | -925.48K | -1.70M | -1.24M | -359.35K |
Income tax expense | 24.5K | 102.4K | 1.54K | 4.82K | 61.54K | -92.19K |
Net income | -11.68M | -1.36M | -927.02K | -1.70M | -1.24M | -278.05K |
Earnings per share | ||||||
Basic EPS | -0.03 | -0.00 | -0.00 | -0.06 | -0.05 | -0.01 |
Diluted EPS | -0.03 | -0.00 | -0.00 | -0.06 | -0.05 | -0.01 |
| Data source | Data source | Data source | Data source | Data source | Data source |